popular prescriptions
Currently, Medicare does not cover drugs specifically prescribed for weight loss, but it will cover GLP-1 class drugs prescribed for other conditions, such as type 2 diabetes. For example, Wegovy is applicable when prescribed to relieve symptoms. Risk of heart attack or stroke Obese or overweight adults. However, the Biden administration took office in November. Proposed reinterpretation of Medicare prescription coverage Regulations allowing insurance coverage of “anti-obesity drugs.”
Such a move is reportedly part of discussions Lilly’s CEO plans to bring to the Trump administration. Rix has the potential to reduce long-term health care costs by improving people’s overall health through GLP-1 drug coverage, rather than using drug price negotiations to reduce health care costs. We aim to make the most of it. The argument likely targets Mehmet Oz, the television host and heart surgeon whom President Trump has nominated to run the Centers for Medicare and Medicaid Services.
“My argument to Mehmet Oz is that if you want to protect Medicare costs over a 10-year period, [the Affordable Care Act] “Right now, these drugs are listed in Medicare plans, and we have a good idea of how much downstream cost savings there are for heart disease and other diseases,” Ricks told Bloomberg.
October report from the Congressional Budget Office However, he strongly disputed this claim. CBO estimates that direct Medicare costs for anti-obesity drugs from 2026 to 2034 will be nearly $39 billion, but savings from health improvements will total just over $3 billion, netting U.S. taxpayers The cost will be approximately $35.50. Billion.
